Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 24Terminated 10Recruiting 9Active not recruiting 6Unknown 4Withdrawn 2Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Other solid neoplasm 4Other 1Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 26Carcinoma, Renal Cell 10Melanoma 4Urinary Bladder Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Hyperplasia 1Penile Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nocturia 1Nephrolithiasis, Calcium Oxalate 1Multiple Myeloma 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Metastatic Castrate Resistant Prostate Cancer 1Mesothelioma 1

Interventions

Paclitaxel 1Etoposide 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Mesothelioma × Genitourinary × Clear all
NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡